There was a time when Maxim seemed unstoppable, with its alluring combination of not-quite-supermodels baring not-quite-everything and articles that often acted as advertisements for boxer briefs and ...

It was a case of good news and bad news at Maxim. The magazine of beer and babes turned a profit in 2018, its first since Sardar Biglari took over in 2014. But the mag has not turned the corner for ...

Maxim analyst Jason McCarthy notes that earlier this week, Sellas announced an update on the ongoing Phase 3 REGAL trial evaluating Galipepimut-S ...

For decades, Maxim has held a unique and influential position within the global media landscape, evolving from a pioneering men’s magazine to a dynamic, multi-platform lifestyle brand that ...

As previously reported, Maxim upgraded CNS Pharmaceuticals (CNSP) to Buy from Hold with a $20 price target The company has pivoted to its oncology asset TPI-287, a blood brain barrier crossing taxane ...

The thing about Maxim is that it used to be great. Well, maybe “great” isn’t the perfect word, but it did fundamentally restructure the media world. For decades, publishers assumed they couldn’t sell ...

It was a case of Maxim-um misogyny. A mere week after getting shamed over its resurfaced “unsexiest women” countdown, Maxim is under fire yet again for another “sexist” hit piece from the early 2000s.